Day: February 5, 2026

Cross Keys Capital Advises Montana Retina Consultants in Its Partnership with Retina Consultants of America

Written by Customer Service on February 5, 2026. Posted in Mergers And Acquisitions.

Fort Lauderdale, FL, Feb. 05, 2026 (GLOBE NEWSWIRE) — Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to physician group practices and healthcare services companies, is pleased to announce it acted as the exclusive financial advisor to Montana Retina Consultants in its partnership with Retina Consultants of America (RCA). Montana Retina Consultants is a community-based retinal care practice in Bozeman, Montana, treating a wide range of retinal diseases including diabetic retinopathy, retinal tears, macular degeneration, central serous chorioretinopathy, choroidal nevus, lattice degeneration, macular edema, retinal detachment, vein occlusion and vitreomacular adhesion. The deal team consisted of Jeanne Proia, Chris Gammill, and Andres Poveda. Led by Dr. Marc Comaratta,...

AFC Provides $60 Million Senior Secured Credit Facility to Support the Combination of STAT Recovery Services and The Moresby Group

Written by Customer Service on February 5, 2026. Posted in Mergers And Acquisitions.

Facilitating Cambridge Capital’s Strategy to Create a Leading Revenue and Cost Optimization Platform WEST PALM BEACH, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) — AFC today announced that its wholly owned subsidiary TCGDL LLC has closed a $60 million senior secured credit facility to STAT Buyer, LLC, a holding company controlled by Cambridge Capital (“Cambridge”), formed to facilitate the combination of its existing portfolio company STAT with The Moresby Group (“Moresby”). The proceeds from the credit facility will be used to finance the acquisition, refinance existing debt, and provide working capital to support the growth of the combined entity. “We are excited to support Cambridge and the management teams of STAT and Moresby in this transformative transaction. This combination brings together STAT’s machine-learning enabled revenue...

Volaris Automotive Expands in Dutch Market with WinCar Acquisition

Written by Customer Service on February 5, 2026. Posted in Mergers And Acquisitions.

TORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) — Volaris Automotive, an acquirer of specialized software companies serving the automotive industry, today announced the acquisition of WinCar Automotive ICT Solutions (“WinCar”), a prominent provider of dealer management systems in the Netherlands. This furthers Volaris Automotive’s mandate to expand its worldwide reach in the auto sector. Founded more than 30 years ago in Zevenaar, Netherlands, WinCar offers modular software that automates business processes for garages and dealerships across the Dutch market. With this acquisition by Volaris Automotive, WinCar joins a global organization of like-minded software providers serving the automotive industry. Head of Volaris Automotive Werner Leinauer commented, “WinCar has built a strong reputation over more than three decades by delivering...

Byrna Technologies Reports Record Fiscal Fourth Quarter and Full Year 2025 Results; Full Year Revenue Up 38% Year-over-Year

Written by Customer Service on February 5, 2026. Posted in Earnings Releases And Operating Results.

Expands Monthly Production Capacity by 33% to Support Growing Demand ANDOVER, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) — Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today reported select financial results for its fiscal fourth quarter (“Q4 2025”) and full year ended November 30, 2025. Fiscal Fourth Quarter 2025 and Recent Operational HighlightsSurpassed 750,000 launchers sold since inception, increasing cumulative unit sales by more than 250,000 units during fiscal 2025. Expanded monthly production capacity to 20,000 units to support growing demand, including larger than anticipated dealer reorders entering fiscal 2026. Appointed Adam Roth, former Vice President...

Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST), Westwood Salient Enhanced Energy Income ETF (WEEI) and Westwood Enhanced Income Opportunity (YLDW)

Written by Customer Service on February 5, 2026. Posted in Dividend Reports And Estimates.

DALLAS, Feb. 05, 2026 (GLOBE NEWSWIRE) — Westwood Holdings Group (WHG), a publicly-traded investment management boutique and wealth management firm, today announced monthly income distributions for Westwood Salient Enhanced Midstream Income ETF (NYSE: MDST), Westwood Salient Enhanced Energy Income ETF (NASDAQ: WEEI) and Westwood Enhanced Income Opportunity (YLDW) as shown in the table below. Part of the Westwood Income Series ETFs, these deliver income from both dividends and options premiums to help provide monthly income distributions for investors.ETF Ticker ETF Distribution per Share Annualized Distribution Rate1(NYSE:MDST) Westwood Salient Enhanced Midstream Income ETF 0.225 9.9%(NASDAQ:WEEI) Westwood Salient Enhanced Energy Income ETF 0.225 11.9%(NYSE: YLDW) Westwood Enhanced Income Opportunity 0.149 7.0%MDST,...

CEO Shareholder Letter: Alpha Modus Positions Itself as a Consumer-Facing IP Linchpin in AI-Enabled Physical Retail

Written by Customer Service on February 5, 2026. Posted in Public Companies.

CORNELIUS, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) — The CEO and Founder, William Alessi, of Alpha Modus Holdings, Inc. (“Alpha Modus”) (NASDAQ: AMOD), provides an open letter to shareholders. Highlights:Avoidance of toxic 3rd party post-SPAC financing: Cap table preservation Consumer-facing IP litigation: Enforcement proven, scaleup expected Alpha Cash: Foundation built, pilot in underway Q1 2026, ready to scale Capital needs have been strategically aligned: Company has no concerns over operating capital needs for the foreseeable future.Dear Fellow Shareholders, Since Alpha Modus became a public company, we have been deliberate in both our strategy and our execution. Rather than chasing short-term optics or reacting to market pressures, we have focused on building durable, long-term leverage across our intellectual property,...

BitFuFu Announces January 2026 Bitcoin Production and Operational Updates

Written by Customer Service on February 5, 2026. Posted in Public Companies.

BitFuFu’s January 2026 Bitcoin Production and Operational UpdatesBitFuFu produced 229 Bitcoin in January 2026 amid expanded hashrate, power capacity, and improved fleet efficiency.BitFuFu Holds 1,796 BTCBitFuFu’s Bitcoin holdings grew to 1,796 BTC as of January 31, 2026.SINGAPORE, Feb. 05, 2026 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited Bitcoin production and operational metrics for January 2026. “In January we increased our managed hashrate and power capacity while improving fleet efficiency to mine more Bitcoin at lower cost. Despite recent Bitcoin price volatility, we remain confident in Bitcoin’s long-term value and will continue expanding both our mining capacity and Bitcoin...

Edible Garden to Participate in ECRM’s Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session, February 10–12, 2026

Written by Customer Service on February 5, 2026. Posted in Public Companies.

BELVIDERE, NJ, Feb. 05, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that it will participate in ECRM’s Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session, taking place February 10–12, 2026, at the Hyatt Regency Chicago O’Hare in Rosemont, Illinois. ECRM’s Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session brings together leading brands and top retail buyers through curated, one-on-one meetings designed to drive meaningful product discovery and commercial partnerships. Unlike traditional trade shows, ECRM’s highly targeted format enables brands to engage directly with decision-makers...

FLSmidth announces preliminary and unaudited results for 2025 and full-year 2026 financial guidance

Written by Customer Service on February 5, 2026. Posted in Public Companies.

COMPANY ANNOUNCEMENT NO. 09-2026 FLSmidth & Co. A/S 5 February 2026 Copenhagen, DenmarkToday, FLSmidth & Co. A/S (FLSmidth) announces preliminary and unaudited financial key results for the full year 2025 and introduces its financial guidance for the full year 2026 FLSmidth hereby announces preliminary and unaudited financial figures for the full year 2025. The preliminary financial figures are awaiting finalisation of the company’s independent, customary audit procedures and are therefore subject to change. The preliminary, unaudited financial figures exceed the expectations set out in the FLSmidth’s latest financial guidance for the full year 2025 (ref. Company Announcement no. 41-2025):Revenue is expected to be DKK 14.6bn, which is in line with the latest financial guidance of around DKK 14.5bnAdjusted EBITA margin...

IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY

Written by Customer Service on February 5, 2026. Posted in Public Companies.

Strategic Restructuring Eliminates Expenses Not Essential to the Phase 3 Study Khursheed Anwer, Ph.D., Executive Vice President and Chief Scientific Officer, will retire after nearly 12 years at the company Phase 3 Study enrollment remains ahead of schedule and advances the company toward future BLA filing LAWRENCEVILLE, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced a strategic reorganization that will eliminate headcount not essential to the Phase 3 trial and redefine the job descriptions for additional employees to reduce operating expenses while supporting the company’s focused strategy to rapidly advance the pivotal OVATION 3 Phase 3 clinical trial in women with newly diagnosed advanced ovarian cancer....

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Day: February 5, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals